To P2P, or not to P2P? That is the question…

21.4.2020

In the wake of the completing of the National Veterinary Care sale to VetPartners, we thought it would be interesting to present a summary of P2P transactions in Australia over the last 2 years, and see what the data tells us about P2P. P2P simply means the takeover of a listed (public) company so that it then becomes a private company, either independently (typically with the backing of a financial sponsor) or as part of a larger company (ie. a strategic buyer).

Over the last 2 years in Australia, 56 listed companies have been the subject of public to private (P2P) takeover attempts.

Of the 56 P2Ps in the last 2 years:

  • 19 have been from international strategic investors, eg. DuluxGroup (Nippon Paint – Japan), GBST Holdings (FNZ Group – UK), Ruralco (Nutrien – Canada), Bellamys Australia (China Mengniu Dairy – China), ERM Power (Shell – Netherlands);
  • 15 have been from International private equity investors, eg. MYOB (KKR), Scottish Pacific (Affinity Equity Partners), Greencross Vets (TPG);
  • 11 have been from Australian strategic investors, eg. Fairfax Media (Nine Entertainment), Xenith IP (IPH), Chalmers (Qube Logistics); and
  • 11 have been from Australian private equity investors, eg. Navitas (BGH consortium), and Zenitas Healthcare (Adamantem).

Given the number of transactions that have occurred, we decided to run the numbers to see what premiums are being paid, and the factors that influence this premium.

Focusing on the takeover price compared to the 3-month VWAP (Volume Weighted Average Price):

  • The average premium across all transactions was 41%;
  • The average for strategic investors was 53%, compared to 33% for PE deals;
  • The average for successful deals was 43%, compared to 23% for unsuccessful deals;
  • Where a strategic investor was involved, the average premium paid by international investors was 57%, compared to 48% for local buyers;
  • The average where there were multiple bidders was 43%, compared to 40% where there was only one bidder.

The summarised data is presented in the following table.

These conclusions confirm what you would expect, and highlight that there can be a substantial difference in the price paid depending on the nature of the investor. Listed takeover targets can’t always control their fate, but they can control their preparation. We recommend always having a defence pack ready, and a plan for how to engage the bidders most likely to pay a strategic premium.

29.5.2026

Sector dashboards May 2026

Our monthly sector dashboards are out! Our dashboards look at the valuation multiples across seven key sectors, each made up of a number of subsectors. The data takes into account the sale prices of similar companies based on; products, end markets, services, assets classes or other characteristics. The publications include all companies listed on the […]

Read more
28.5.2026

InterFinancial advises Commit Works on sale to Datamine

Commit Works is a Brisbane-based software company serving the mining and metals industry. Its CiteOps platform digitises shift-level planning, resource allocation, task coordination and production tracking, connecting the short-term plan to what actually happens on shift across underground coal, open cut, underground hardrock and smelter operations globally. Datamine is the world’s leading provider of technology […]

Read more
29.4.2026

Sector dashboards April 2026

Our monthly sector dashboards are out! Our dashboards look at the valuation multiples across seven key sectors, each made up of a number of subsectors. The data takes into account the sale prices of similar companies based on; products, end markets, services, assets classes or other characteristics. The publications include all companies listed on the […]

Read more
29.4.2026

From technical capability to economic inevitability: Why Clean Energy companies fail to scale?

Working with organisations attempting to commercialise clean energy technologies, I have observed a pattern persistent enough to warrant explicit articulation. Across hydrogen, electrification, storage, biogas, low-carbon fuels, and industrial heat, companies with credible technology, capable teams, and supportive boards still fail to compound enterprise value. Not because the technology disappoints, and not because the market […]

Read more
31.3.2026

Sector dashboards March 2026

Our monthly sector dashboards are out! Our dashboards look at the valuation multiples across seven key sectors, each made up of a number of subsectors. The data takes into account the sale prices of similar companies based on; products, end markets, services, assets classes or other characteristics. The publications include all companies listed on the […]

Read more
31.3.2026

Not every healthcare deal is a sale: rethinking what M&A can look like

When healthcare business owners come to us thinking about a transaction, the conversation almost always starts in the same place. What is the business worth, and what does a sale process look like? Those are the right questions. But they’re not always the only ones that matter. Embedded in both is an assumption; that the […]

Read more
27.2.2026

Sector dashboards February 2026

Our monthly sector dashboards are out! Our dashboards look at the valuation multiples across seven key sectors, each made up of a number of subsectors. The data takes into account the sale prices of similar companies based on; products, end markets, services, assets classes or other characteristics. The publications include all companies listed on the […]

Read more
27.2.2026

On the floor at EvokeAg 2026: Luke Harwood’s reflections on Australian Agtech

EvokeAg 2026 drew over 1,500 delegates from 18 countries to Melbourne in February, with the Federal Government committing another $450,000 to support the event over the next three years. The visible momentum is real, and the cohort of companies I spent two days meeting reflected it. Most were past proof-of-concept by a meaningful margin, with […]

Read more